These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers. Cirello V; Colombo C; Karapanou O; Pogliaghi G; Persani L; Fugazzola L Front Endocrinol (Lausanne); 2020; 11():589340. PubMed ID: 33488516 [TBL] [Abstract][Full Text] [Related]
3. HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer. Weeks AL; Wilson SG; Ward L; Goldblatt J; Hui J; Walsh JP BMC Med Genet; 2016 Aug; 17(1):60. PubMed ID: 27530615 [TBL] [Abstract][Full Text] [Related]
5. CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function. Pires C; Marques IJ; Valério M; Saramago A; Santo PE; Santos S; Silva M; Moura MM; Matos J; Pereira T; Cabrera R; Lousa D; Leite V; Bandeiras TM; Vicente JB; Cavaco BM J Biol Chem; 2024 Mar; 300(3):105767. PubMed ID: 38367672 [TBL] [Abstract][Full Text] [Related]
6. HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer. Zhang T; Xing M J Natl Cancer Inst; 2016 Jun; 108(6):djv415. PubMed ID: 26832773 [TBL] [Abstract][Full Text] [Related]
7. An update on familial nonmedullary thyroid cancer. Ammar SA; Alobuia WM; Kebebew E Endocrine; 2020 Jun; 68(3):502-507. PubMed ID: 32162184 [TBL] [Abstract][Full Text] [Related]
8. Identification of susceptibility gene mutations associated with the pathogenesis of familial nonmedullary thyroid cancer. Zhu J; Wu K; Lin Z; Bai S; Wu J; Li P; Xue H; Du J; Shen B; Wang H; Liu Y Mol Genet Genomic Med; 2019 Dec; 7(12):e1015. PubMed ID: 31642198 [TBL] [Abstract][Full Text] [Related]
10. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma. Ye F; Gao H; Xiao L; Zuo Z; Liu Y; Zhao Q; Chen H; Feng W; Fu B; Sun L; Jiang X; He D; Jiang H; Yang M; Li L; Chen F; Liu X; Li S; Li Z; Jiang Y; Cheng L; Bu H Int J Cancer; 2019 Mar; 144(6):1321-1330. PubMed ID: 30132833 [TBL] [Abstract][Full Text] [Related]
11. Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review. Colombo C; Muzza M; Proverbio MC; Ercoli G; Perrino M; Cirello V; Vicentini L; Ferrero S; Fugazzola L Clin Endocrinol (Oxf); 2017 Jun; 86(6):837-844. PubMed ID: 28222214 [TBL] [Abstract][Full Text] [Related]
12. Letter regarding the article: "Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls" by Kern et al. Colombo C; Fugazzola L; Muzza M; Proverbio MC; Cirello V Eur J Med Genet; 2018 Feb; 61(2):104-105. PubMed ID: 28779995 [TBL] [Abstract][Full Text] [Related]
14. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. Sippel RS; Caron NR; Clark OH World J Surg; 2007 May; 31(5):924-33. PubMed ID: 17429563 [TBL] [Abstract][Full Text] [Related]
15. Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population. de Randamie R; Martos-Moreno GÁ; Lumbreras C; Chueca M; Donnay S; Luque M; Regojo RM; Mendiola M; Hardisson D; Argente J; Moreno JC Horm Res Paediatr; 2018; 89(6):397-407. PubMed ID: 29895015 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of familial nonmedullary thyroid carcinoma. Fan YF; Zhang B; Yang X; Shang ZH; Liu HF; Xie Y; Liu YW; Gao WS; Wu Q; Li XY Chin Med J (Engl); 2015 Apr; 128(8):1037-41. PubMed ID: 25881596 [TBL] [Abstract][Full Text] [Related]
17. Orois A; Gara SK; Mora M; Halperin I; Martínez S; Alfayate R; Kebebew E; Oriola J Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31703244 [TBL] [Abstract][Full Text] [Related]
18. Germ-line mutations in Zhao Y; Yu T; Sun J; Wang F; Cheng C; He S; Chen L; Xie D; Fu L; Guan X; Yan A; Li Y; Miao G; Zhu X Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326253 [TBL] [Abstract][Full Text] [Related]
19. Is Familial Nonmedullary Thyroid Cancer A More Aggressive Type of Thyroid Cancer? Muallem Kalmovich L; Jabarin B; Koren S; Or K; Marcus E; Tkacheva I; Benbassat C; Steinschneider M Laryngoscope; 2021 Feb; 131(2):E677-E681. PubMed ID: 32761812 [TBL] [Abstract][Full Text] [Related]
20. Novel Susceptibility Genes Drive Familial Non-Medullary Thyroid Cancer in a Large Consanguineous Kindred. Majdalani P; Yoel U; Nasasra T; Fraenkel M; Haim A; Loewenthal N; Zarivach R; Hershkovitz E; Parvari R Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]